Depressive disorder biomarker and use thereof
A biomarker and depression technology, applied in the field of biomedicine, can solve problems such as depression that needs to be improved, and achieve the effects of facilitating early prediction, improving diagnostic accuracy, and simplifying the diagnostic process
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0064] In this example, high-throughput sequencing was used to analyze stool samples from healthy people and patients with depression in batches. Based on the high-throughput sequencing data, a statistical test is performed on the healthy population and the depression patient population, so as to determine the specific nucleic acid sequence related to the depression patient population. Specific steps are as follows:
[0065] 1. Sample source
[0066] Depression group: 18 outpatients and inpatients in Shenzhen Kangning Hospital from January 2015 to 2016 were selected, including 10 males and 8 females. The age of the patients was 44.73±12.54 years old, and the BMI index was (22.59± 3.76), the total course of disease was (94.18±64.97) months, and the number of attacks was (4.68±9.21) times. Inclusion criteria: ①Meet the diagnostic criteria of ICD-10 and DSM-5 for unipolar depression; ②Age between 30-65 years old, with 2 or more episodes; ③(Hamilton Depression Rating Scale (HAMD-17
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap